Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options

Z Sas, E Cendrowicz, I Weinhäuser… - International Journal of …, 2022 - mdpi.com
The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in
Europe and the USA in recent decades. Among the different subtypes of liver cancers …

TGF‐β signalling and liver disease

I Fabregat, J Moreno‐Càceres, A Sánchez… - The FEBS …, 2016 - Wiley Online Library
The transforming growth factor‐beta (TGF‐β) family signalling pathways play essential roles
in the regulation of different cellular processes, including proliferation, differentiation …

TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells

DH Kim, WD Kim, SK Kim, DH Moon, SJ Lee - Cell death & disease, 2020 - nature.com
Abstract System xc− contributes to glutathione (GSH) synthesis and protects cells against
ferroptosis by importing cystine and exchanging it with glutamate. Transforming growth …

TGF-beta signaling in cancer treatment

I Fabregat, J Fernando, J Mainez… - Current pharmaceutical …, 2014 - ingentaconnect.com
The transforming growth factor-beta (TGF-!) belongs to a superfamily of cytokines that act on
protein kinase receptors at the plasma membrane to induce a plethora of biological signals …

The TGF-β pathway: a pharmacological target in hepatocellular carcinoma?

E Gonzalez-Sanchez, J Vaquero… - Cancers, 2021 - mdpi.com
Simple Summary Transforming Growth Factor-beta (TGF-β) signaling is crucial to maintain
tissue homeostasis. Alterations in TGF-β signaling impact tissue functions and favor the …

New insights into the crossroads between EMT and stemness in the context of cancer

I Fabregat, A Malfettone, J Soukupova - Journal of clinical medicine, 2016 - mdpi.com
The epithelial-mesenchymal transition (EMT) is an example of cellular plasticity, where an
epithelial cell acquires a mesenchymal-like phenotype that increases its migratory and …

Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome

E Crosas-Molist, T Meirelles… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—Marfan's syndrome is characterized by the formation of ascending aortic
aneurysms resulting from altered assembly of extracellular matrix microfibrils and chronic …

A mesenchymal‐like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells

J Fernando, A Malfettone, EB Cepeda… - … journal of cancer, 2015 - Wiley Online Library
The multikinase inhibitor sorafenib is the only effective drug in advanced cases of
hepatocellular carcinoma (HCC). However, response differs among patients and …

Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B

GH Qiu, X Xie, F Xu, X Shi, Y Wang, L Deng - Cytotechnology, 2015 - Springer
As cellular models for in vitro liver cancer and toxicity studies, HepG2 and Hep3B are the
two most frequently used liver cancer cell lines. Because of their similarities they are often …

Molecular targets and signaling pathways of microRNA-122 in hepatocellular carcinoma

KH Chun - Pharmaceutics, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading global causes of cancer mortality.
MicroRNAs (miRNAs) are small interfering RNAs that alleviate the levels of protein …